Project Oncology®

Episodes 1-16 of 21

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Helena Yu, MD

    Peer

  2

  

  RestartResume

  RestartResume

  0.25 creditsKeeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC

  0.25 credits

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Gilberto de Lima Lopes Junior, MD, MBA, FAMS

    Peer

  3

  

  RestartResume

  RestartResume

  0.25 creditsKeeping Pace: The Use of Immunotherapy in Mutation-Positive Non-Small Cell Lu...

  0.25 credits

• • 

    

    William J. Gradishar MD, FASCO, FACP

    Peer

  • 

    

    Peter Schmid, FRCP, MD, PhD

    Peer

  3

  

  RestartResume

  RestartResume

  0.25 creditsPerspectives for Clinical Practice: The Latest Advances for HER2-positive Met...

  0.25 credits

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  2

  

  RestartResume

  RestartResume

  0.25 creditsKeeping Pace: The Role of Immunotherapy After Disease Progression

  0.25 credits

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Suresh S. Ramalingam, MD

    Peer

  4

  

  RestartResume

  RestartResume

  0.25 creditsKeeping Pace: The Role of Immunotherapy in the Frontline Setting

  0.25 credits

• • 

    

    Warner K. Huh, MD

    Peer

  • 

    

    Deborah K. Armstrong, MD

    Peer

  • 

    

    Robert L. Coleman, MD, FACOG, FACS

    Peer

  5

  

  RestartResume

  RestartResume

  0.25 creditsKeeping Pace in Women's Cancer: The Role of PARP Inhibitors in Ovarian Cancer

  0.25 credits

• • 

    

    Peter H. O'Donnell, MD

    Peer

  • 

    

    Daniel P. Petrylak, MD

    Peer

  12

  

  RestartResume

  RestartResume

  0.25 creditsKeeping Pace: Emerging Treatment Considerations in Metastatic Urothelial Cancer

  0.25 credits

• • 

    

    Mark A. Socinski, MD

    Peer

  2

  

  RestartResume

  RestartResume

  0.25 creditsKey Highlights from the Latest Clinical Trials in Lung Cancer

  0.25 credits

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Nabil Wasif, MD

    Peer

  5

  

  RestartResume

  RestartResume

  HIPEC: A Novel Treatment for Advanced Abdominal Cancers
• 43

  

  RestartResume

  RestartResume

  Innovative Molecules in Immuno-Oncology: Revolutionizing Cancer Treatment

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Ronald DeMatteo, MD, FACS

    Peer

  14

  

  RestartResume

  RestartResume

  What to Know About a State-of-the-Art Approach to GIST Treatment

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Robert Vonderheide, MD

    Peer

  23

  

  RestartResume

  RestartResume

  CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Harish Lavu, MD

    Peer

  10

  

  RestartResume

  RestartResume

  Pancreatic Cancer: The Hunt to Catch a Silent Killer

• • 

    

    James "Tate" Thigpen, MD

    Peer

  • 

    

    Kristi Orbaugh, MSN, RNP, AOCN

    Peer

  5

  

  RestartResume

  RestartResume

  Dialogue with the Experts: Best Practices in NSCLC

• • 

    

    Brian P. McDonough, MD, FAAFP

    Peer

  2

  

  RestartResume

  RestartResume

  Linking p53 Variation to Breast Cancer Risk in African American Women

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Major Kenneth Lee, IV, MD, PhD

    Peer

  27

  

  RestartResume

  RestartResume

  Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment App...

• Prev
• 1
• 2
• Next